High Court holds that 20th Century Fox’s Glee infringes Comic Enterprises’ trademark for a logo including the words ‘the Glee Club’
Comic Enterprises established its first live entertainment venue in Birmingham in 1994 and now operates venues in Cardiff, Oxford and Nottingham. The venues are primarily used for stand-up comedy and live music.
In 1999, it registered UK trademark 2200698 in relation to a number of services, including entertainment services, comedy services, the provision of live and recorded music and the production and presentation of live shows. The trademark is a series of two marks.
The two marks are identical except that the first in the series is stated to be claimed in the colours red, black and white whereas the second is represented in black and white with no claim to colour. Fox’s television series Glee follows a US high-school singing club at the fictional William McKinley High School in the town of Lima, Ohio. Examples of its use of the sign ‘Glee’ are as follows…
Click on the link below to read the rest of the Wragge & Co briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
Ruling on an application for specific disclosure could have big implications in the early stages of procurement disputes.
Hospira v Genentech III: Swiss form claim obvious in view of paper reporting the existence of Phase III trial
Arnold J has delivered the latest blow in the ongoing saga surrounding trastuzumab (the monoclonal antibody in Herceptin) and Hospira’s continued efforts to knock out Genentech’s patents.